The European Food Safety Authority (EFSA) approved Arla Foods Ingredients’ Peptigen® IF-3080 for infant formula and follow-on formula products in the EU.
In February 2022, the EU introduced new regulations requiring the evaluation of the safety and suitability of all protein hydrolysates used in formulas.
Shortly afterward, the European Food Safety Agency (EFSA) published an opinion that Peptigen® IF-3080 was safe and suitable for formulas and follow-on formulas in the EU. It was one of only a few milk protein hydrolysates to achieve this status.
Now the product has been included in the Commission Delegated Regulation (EU) 2016/7 – the final step necessary for it to be used in infant formula and follow-on formulas sold across the EU.
Anders Steen Jørgensen, Head of Arla Foods Ingredients’ Paediatric Business Unit, said: “It’s great news that Peptigen® IF-3080 has completed its journey to market in the EU. Safety and quality are paramount in infant nutrition, and this decision reflects our absolute commitment to the highest possible standards. We believe it will benefit manufacturers developing innovative products and increase the choice of high-quality formula available to parents.”
About Arla Foods Ingredients
Arla Foods Ingredients is a global leader in value-added whey solutions. We discover and deliver ingredients derived from whey, supporting the food industry with the development and efficient processing of more natural, functional, and nutritious foods. We serve global markets within early life nutrition, medical nutrition, sports nutrition, health foods, and other foods and beverage products.
